ROLLINS INC (ROL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 500M 1B 1.5B Q3 '21: 700M Q4 '21: 727.5M Q1 '22: 744.1M Q2 '22: 780.6M Q3 '22: 799.9M Q4 '22: 802.7M Q1 '23: 820.4M Q2 '23: 855.7M Q3 '23: 887M Q4 '23: 915.2M Q1 '24: 941.9M Q2 '24: 958.1M Q3 '24: 988.1M Q4 '24: 1B Q1 '25: 1B Q2 '25: 1.1B Q3 '25: 1.1B Q4 '25: 1.1B Q1 '26: 1.2B Q2 '26: 1.2B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 350M 700M 1.1B Q1 '15: 714.6M Q2 '15: 729.8M Q3 '15: 738M Q4 '15: 749.3M Q1 '16: 761.4M Q2 '16: 774.6M Q3 '16: 788.8M Q4 '16: 801.1M Q1 '17: 812.3M Q2 '17: 826.2M Q3 '17: 839.4M Q4 '17: 854M Q1 '18: 870.5M Q2 '18: 891.1M Q3 '18: 910.9M Q4 '18: 927.1M Q1 '19: 936.3M Q2 '19: 957.3M Q3 '19: 993.6M Q4 '19: 1B Q2 '15 Q1 '16 Q4 '16 Q3 '17 Q2 '18 Q1 '19 Q4 '19

Operating Income TTM

0 250M 500M 750M Q4 '21: 447.6M Q1 '22: 452.8M Q2 '22: 454M Q3 '22: 472.5M Q4 '22: 493.4M Q1 '23: 512.2M Q2 '23: 532.4M Q3 '23: 564.1M Q4 '23: 583.2M Q1 '24: 603.4M Q2 '24: 631M Q3 '24: 645.7M Q4 '24: 657.2M Q1 '25: 667.4M Q2 '25: 683.4M Q3 '25: 716.6M Q4 '25: 726.1M Q1 '26: 728.9M Q2 '26: 731.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

0 200M 400M 600M Q3 '21: 353.9M Q4 '21: 356.6M Q1 '22: 337.7M Q2 '22: 340.5M Q3 '22: 355.5M Q4 '22: 368.6M Q1 '23: 383.1M Q2 '23: 391.6M Q3 '23: 410.4M Q4 '23: 435M Q1 '24: 441.1M Q2 '24: 460.4M Q3 '24: 469.5M Q4 '24: 466.4M Q1 '25: 477.2M Q2 '25: 489.3M Q3 '25: 515.9M Q4 '25: 526.7M Q1 '26: 529.3M Q2 '26: 531.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 700M 1.4B 2.1B Q3 '21: 1.1B Q4 '21: 1.2B Q1 '22: 1.2B Q2 '22: 1.2B Q3 '22: 1.3B Q4 '22: 1.3B Q1 '23: 1.3B Q2 '23: 1.4B Q3 '23: 1.4B Q4 '23: 1.5B Q1 '24: 1.5B Q2 '24: 1.5B Q3 '24: 1.6B Q4 '24: 1.6B Q1 '25: 1.6B Q2 '25: 1.7B Q3 '25: 1.7B Q4 '25: 1.8B Q1 '26: 1.8B Q2 '26: 1.9B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 250M 500M 750M Q3 '21: 394.1M Q4 '21: 401.8M Q1 '22: 369.9M Q2 '22: 397.4M Q3 '22: 445.4M Q4 '22: 465.9M Q1 '23: 479.2M Q2 '23: 499.3M Q3 '23: 498.9M Q4 '23: 528.4M Q1 '24: 555M Q2 '24: 552.7M Q3 '24: 572.3M Q4 '24: 607.7M Q1 '25: 627.1M Q2 '25: 657.1M Q3 '25: 701.5M Q4 '25: 678.1M Q1 '26: 649.6M Q2 '26: 647M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 250M 500M 750M Q3 '21: 368.5M Q4 '21: 374.6M Q1 '22: 342.5M Q2 '22: 367.6M Q3 '22: 415.3M Q4 '22: 435.3M Q1 '23: 448.9M Q2 '23: 470.1M Q3 '23: 469.9M Q4 '23: 495.9M Q1 '24: 523M Q2 '24: 518.8M Q3 '24: 537.7M Q4 '24: 580.1M Q1 '25: 599.9M Q2 '25: 631.6M Q3 '25: 675M Q4 '25: 650M Q1 '26: 621.1M Q2 '26: 619.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 200M 400M 600M Q1 '18: 218.2M Q2 '18: 218.2M Q3 '20: 492.1M Q1 '21: 492M Q2 '21: 492M Q3 '21: 492.1M Q1 '22: 492.3M Q2 '22: 492.4M Q3 '22: 492.4M Q1 '23: 492.7M Q2 '23: 492.9M Q3 '23: 491M Q1 '24: 484.3M Q2 '24: 484.4M Q3 '24: 484.4M Q1 '25: 484.4M Q2 '25: 484.7M Q3 '25: 484.7M Q1 '26: 481.4M Q2 '26: 481.4M Q2 '18 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.40 0.80 1.20 Q3 '21: 0.72 Q4 '21: 0.72 Q1 '22: 0.68 Q2 '22: 0.69 Q3 '22: 0.72 Q4 '22: 0.75 Q1 '23: 0.78 Q2 '23: 0.79 Q3 '23: 0.83 Q4 '23: 0.89 Q1 '24: 0.90 Q2 '24: 0.95 Q3 '24: 0.97 Q4 '24: 0.96 Q1 '25: 0.99 Q2 '25: 1.01 Q3 '25: 1.07 Q4 '25: 1.09 Q1 '26: 1.09 Q2 '26: 1.10 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.